비교리스트

 카트 문의
시장보고서
상품코드
1616397

세계의 오메가 3 시장 규모 : 유형별, 유래별, 용도별, 지역별, 범위 및 예측

Global Omega 3 Market Size By Type (Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA)), By Source (Marine Source, Plant Source), By Application (Dietary Supplements, Functional Food And Beverages), By Geographic Scope And Forecast
발행일: | 리서치사: Verified Market Research | 페이지 정보: 영문 202 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

오메가 3 시장 규모 및 전망

오메가 3 시장 규모는 2021년 21억 달러로 평가되며 2022년부터 2030년까지 연평균 8.21% 성장하여 2030년에는 39억 3,000만 달러에 달할 것으로 예상됩니다. 소비자들 사이에서 건강한 식단과 오메가 3의 건강상의 이점에 대한 인식이 높아지고 임상 연구 및 개발에 대한 투자가 증가함에 따라 향후 몇 년 동안 오메가 3 시장이 촉진될 것으로 예상됩니다. 오메가 3 세계 시장 보고서는 시장에 대한 전반적인 평가를 제공합니다. 주요 부문, 동향, 시장 촉진요인, 억제요인, 경쟁 상황, 시장에서 중요한 역할을 하는 요인 등을 포괄적으로 분석합니다.

세계 오메가 3 시장의 정의

오메가 3 지방산은 심장 질환의 위험을 줄이고 건강한 피부를 촉진합니다. 오메가 3 지방산은 식단과 운동과 함께 섭취하면 혈중 지방(중성지방) 수치를 낮추고 "좋은" 콜레스테롤(HDL) 수치를 높입니다. 또한 고혈압과 자가 면역 질환을 촉진하는 데에도 사용됩니다. 오메가 3 시장은 만성질환의 증가와 함께 계속 변화하고 있습니다. 그것은 오메가 3 지방산(DHA), 오메가 3(EPA), 오메가 3(ALA)와 함께 정렬을 지원하는 것으로 분류됩니다.

세계 오메가 3 시장 개요

고객들 사이에서 불포화지방산의 건강한 식습관 및 건강한 테두리와 관련된 인식이 높아지고 임상 분석 및 시장 개발 분야 부문에 대한 투자가 증가함에 따라 향후 몇 년 동안 오메가 3 시장이 촉진될 것으로 예상됩니다. 또한, 활성 제약 성분(API) 내 제품 사용 증가와 만성질환에 대한 인식이 높아짐에 따라 향후 몇 년 동안 시장이 상승할 것으로 예상됩니다.

또한, 오메가 3가 면역력을 높이고 개와 고양이의 악성 질환 및 염증성 내장 질환과 같은 만성질환을 예방하는 능력은 예측 기간 동안 시장을 활성화시킬 것으로 예상됩니다. 시장 성장을 저해할 수 있는 양면적인 도전도 존재합니다. 엄격한 규제 장벽과 오메가 3 영역 유닛에 대한 더 나은 가격과 같은 요인은 확실히 시장 억제요인으로 작용할 것입니다.

목차

제1장 세계의 오메가 3 시장 소개

  • 시장 개요
  • 조사 범위
  • 가정

제2장 주요 요약

제3장 Verified Market Intelligence 조사 방법

  • 데이터 마이닝
  • 검증
  • 1차 자료
  • 데이터 소스 리스트

제4장 세계의 오메가 3 시장 전망

  • 개요
  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 기회
  • Porter's Five Forces 모델
  • 밸류체인 분석

제5장 세계의 오메가 3 시장, 유형별

  • 개요
  • 도코사헥사엔산(DHA)
  • 에이코사펜타엔산(EPA)
  • α-리놀렌산(Ala)

제6장 오메가 3 세계 시장 : 유래별

  • 개요
  • 해양 유래
  • 식물 유래

제7장 오메가 3 세계 시장, 용도별

  • 개요
  • 식이보충제
  • 기능성 식품 및 음료
  • 의약품
  • 기타

제8장 오메가 3 세계 시장, 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 기타 아시아태평양
  • 세계 기타 지역
    • 라틴아메리카
    • 중동 및 아프리카

제9장 세계의 오메가 3 시장 경쟁 구도

  • 개요
  • 기업 시장 순위
  • 주요 발전 전략

제10장 기업 개요

  • CRODA INTERNATIONAL
  • DSM
  • LONZA
  • ORKLA HEALTH
  • CARGILL
  • CORBION
  • GC RIEBER
  • BASF
  • KD PHARMA
  • EPAX

제11장 부록

  • 관련 조사
ksm 25.01.02

Omega 3 Market Size And Forecast

Omega 3 Market size was valued at USD 2.10 Billion in 2021 and is projected to reach USD 3.93 Billion by 2030 , growing at a CAGR of 8.21% from 2022 to 2030. Rising awareness regarding healthy eating & health benefits of omega-3 among consumers and increasing investment in clinical research & development are expected to drive the Omega 3 Market over the predicted years. The Global Omega 3 Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Omega 3 Market Definition

Omega-3 fatty acids facilitate cut back the danger of cardiopathy and promote healthy skin. This area unit intake in conjunction with diet and exercise to assist lower levels of sure blood fat (triglyceride) and boost levels of "good" cholesteric (HDL). Moreover, it's conjointly wanted to facilitate high-pressure or autoimmune disorders. The ever-changing manner, in conjunction with rising chronic diseases, has contributed to the expansion of the Omega 3 Market. It's classified as supporting the sort together with omega-3 fatty acid (DHA), omega-3 (EPA), and omega-3 (ALA).

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Omega 3 Market Overview

Rising awareness relating to healthy feeding & healthy edges of polyunsaturated fatty acid among customers and increasing investment in clinical analysis & development area units are expected to drive the Omega-3 Market over the expected years. Also, the growing product usage within the Active Pharmaceutical Ingredient (API) and rising awareness of chronic diseases expect to lift the market within the coming years.

Additionally, the power of omega-3 to boost immunity & forestall chronic conditions like malady} & inflammatory internal organ disease in cats and dogs is foretold to fuel the market throughout the forecasted period. There are area unit sure restraints and challenges two-faced which might hinder the market growth. Factors like strict regulation barriers and better prices related to omega-three area units doubtless act as market restraints.

Global Omega 3 Market: Segmentation Analysis

The Global Omega 3 Market is Segmented on the basis of Type, Source, Application, and Geography.

Omega 3 Market, By Type

  • Docosahexaenoic Acid (DHA)
  • Eicosapentaenoic Acid (EPA)
  • Alpha-linolenic Acid (ALA)
  • Based on Type, the market is segmented into
  • Docosahexaenoic Acid (DHA)
  • , Eicosapentaenoic Acid (EPA), and Alpha-linolenic Acid (ALA). Docosahexaenoic Acid (DHA) is predicted to carry the most important market share because of the growing demand for kid formula, which helps in memory retention and learning. Also, it plays a significant role in developing nerve and eye tissues. Global Omega 3 Market, by source

Omega 3 Market, By Source

  • Marine Source
  • Plant Source

Based on Source, the market is segmented into Marine Source and Plant Source. The marine supply is foretold to carry the foremost important CAGR within the forecasted period as DHA and Environmental Protection Agency area unit synthesized by living thing marine organisms like planktons & Protoctista. The consumption of those organisms helps accumulate polyunsaturated fatty acid fatty acids within the body.

Omega 3 Market, By Application

  • Dietary Supplements
  • Functional Food & Beverages
  • Pharmaceuticals
  • Others
  • Based on Application, the market is segmented into
  • Dietary Supplements
  • , Functional Food & Beverages, Pharmaceuticals, and Others. Dietary supplements are units anticipated to own the very best CAGR within the forecasted amount as they're targeted sources of nutrients or alternative substances with an organic process or physiological result.

Omega 3 Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, the Global Omega 3 Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The most important share within the market will be dominated by the Asia Pacific, attributable to the upper demand for fortified food products and the advancements in food technology.

Key Players

  • The "Global Omega 3 Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
  • Croda International, DSM, Lonza, Orkla Health, Cargill, Corbion, GC Rieber, BASF, KD Pharma, and EPAx.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • Partnerships, Collaborations and Agreements
  • On November 2020, Croda International had inked a collaborative partnership with Anomera, an innovative green chemistry Canadian company based in Quebec, focused on developing high-quality Carboxylated Cellulose Nanocrystals which are converted into a micron-sized powder.
  • On January 2021, Croda International Plc, the specialty chemical company that uses innovative science to create high-performance ingredients and technologies that improve lives, announced a global sales and marketing agreement with Genesis Biosciences. This new partnership further expands Croda's existing portfolio of safe and sustainable cleaning raw materials.
  • On June 2021, Lonza and Moderna Announced a Collaboration For Drug Substance Manufacturing of COVID-19 Vaccine Moderna in the Netherlands. A new drug substance production line at Lonza's site in Geleen, Netherlands, will complement the existing production network and support the manufacture of up to an additional 300 million doses per year.
  • On July 2021, Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply. Long-term collaboration for commercial supply of monoclonal antibodies will complete the integrated supply chain to manufacture an antibody-drug conjugate for use against hard-to-treat cancers.
  • Mergers and Acquisitions
  • On April 2021, The KD Pharma Group has acquired the manufacturing assets of a Swiss-based cannabinoid manufacturer. The acquisitions give KD Pharma access to technology for producing Active Pharmaceutical Ingredients based on phytocannabinoids and other plant extracts.
  • On June 2021, Orkla Health acquired NutraQ, and The acquisition will offer Orkla exciting growth opportunities. The health category and direct-to-consumer sales are growing areas and will continue to develop NutraQ's vital concepts while also exploring new possibilities for direct-to-consumer sales.
  • On August 2021, Corbion announced it had acquired Granolife, a Queretaro, Mexico-based provider of functional blends for the Mexican bakery and fortification industries. Granolife employs approximately 60 at its production facility and application in the development center.
  • Product Launches and Product Expansions
  • On January 2021, Corbion increased its capacity for producing lactic acid in North America by around 40% to meet the growing demand for natural ingredients in multiple industries. The investment reinforces the company's leadership position as a supplier of lactic acid and its derivatives worldwide. Corbion also operates lactic acid production facilities in the Netherlands, Brazil, Spain, and Thailand.

TABLE OF CONTENTS

1 INTRODUCTION TO GLOBAL OMEGA 3 MARKET

  • 1.1 OVERVIEW OF THE MARKET
  • 1.2 SCOPE OF REPORT
  • 1.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 DATA MINING
  • 3.2 VALIDATION
  • 3.3 PRIMARY INTERVIEWS
  • 3.4 LIST OF DATA SOURCES

4 GLOBAL OMEGA 3 MARKET OUTLOOK

  • 4.1 OVERVIEW
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
    • 4.2.2 RESTRAINTS
    • 4.2.3 OPPORTUNITIES
  • 4.3 PORTERS FIVE FORCE MODEL
  • 4.4 VALUE CHAIN ANALYSIS

5 GLOBAL OMEGA 3 MARKET, BY TYPE

  • 5.1 OVERVIEW
  • 5.2 DOCOSAHEXAENOIC ACID (DHA)
  • 5.3 EICOSAPENTAENOIC ACID (EPA)
  • 5.4 ALPHA-LINOLENIC ACID (ALA)

6 GLOBAL OMEGA 3 MARKET, BY SOURCE

  • 6.1 OVERVIEW
  • 6.2 MARINE SOURCE
  • 6.3 PLANT SOURCE

7 GLOBAL OMEGA 3 MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 DIETARY SUPPLEMENTS
  • 7.3 FUNCTIONAL FOOD & BEVERAGES
  • 7.4 PHARMACEUTICALS
  • 7.5 OTHERS

8 GLOBAL OMEGA 3 MARKET, BY GEOGRAPHY

  • 8.1 OVERVIEW
  • 8.2 NORTH AMERICA
    • 8.2.1 U.S.
    • 8.2.2 CANADA
    • 8.2.3 MEXICO
  • 8.3 EUROPE
    • 8.3.1 GERMANY
    • 8.3.2 U.K.
    • 8.3.3 FRANCE
    • 8.3.4 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • 8.4.1 CHINA
    • 8.4.2 JAPAN
    • 8.4.3 INDIA
    • 8.4.4 REST OF ASIA PACIFIC
  • 8.5 REST OF THE WORLD
    • 8.5.1 LATIN AMERICA
    • 8.5.2 MIDDLE EAST & AFRICA

9 GLOBAL OMEGA 3 MARKET COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 COMPANY MARKET RANKING
  • 9.3 KEY DEVELOPMENT STRATEGIES

10 COMPANY PROFILES

  • 10.1 CRODA INTERNATIONAL
    • 10.1.1 OVERVIEW
    • 10.1.2 FINANCIAL PERFORMANCE
    • 10.1.3 PRODUCT OUTLOOK
    • 10.1.4 KEY DEVELOPMENTS
  • 10.2 DSM
    • 10.2.1 OVERVIEW
    • 10.2.2 FINANCIAL PERFORMANCE
    • 10.2.3 PRODUCT OUTLOOK
    • 10.2.4 KEY DEVELOPMENTS
  • 10.3 LONZA
    • 10.3.1 OVERVIEW
    • 10.3.2 FINANCIAL PERFORMANCE
    • 10.3.3 PRODUCT OUTLOOK
    • 10.3.4 KEY DEVELOPMENTS
  • 10.4 ORKLA HEALTH
    • 10.4.1 OVERVIEW
    • 10.4.2 FINANCIAL PERFORMANCE
    • 10.4.3 PRODUCT OUTLOOK
    • 10.4.4 KEY DEVELOPMENTS
  • 10.5 CARGILL
    • 10.5.1 OVERVIEW
    • 10.5.2 FINANCIAL PERFORMANCE
    • 10.5.3 PRODUCT OUTLOOK
    • 10.5.4 KEY DEVELOPMENTS
  • 10.6 CORBION
    • 10.6.1 OVERVIEW
    • 10.6.2 FINANCIAL PERFORMANCE
    • 10.6.3 PRODUCT OUTLOOK
    • 10.6.4 KEY DEVELOPMENTS
  • 10.7 GC RIEBER
    • 10.7.1 OVERVIEW
    • 10.7.2 FINANCIAL PERFORMANCE
    • 10.7.3 PRODUCT OUTLOOK
    • 10.7.4 KEY DEVELOPMENTS
  • 10.8 BASF
    • 10.8.1 OVERVIEW
    • 10.8.2 FINANCIAL PERFORMANCE
    • 10.8.3 PRODUCT OUTLOOK
    • 10.8.4 KEY DEVELOPMENTS
  • 10.9 KD PHARMA
    • 10.9.1 OVERVIEW
    • 10.9.2 FINANCIAL PERFORMANCE
    • 10.9.3 PRODUCT OUTLOOK
    • 10.9.4 KEY DEVELOPMENTS
  • 10.10 EPAX
    • 10.10.1 OVERVIEW
    • 10.10.2 FINANCIAL PERFORMANCE
    • 10.10.3 PRODUCT OUTLOOK
    • 10.10.4 KEY DEVELOPMENTS

11 APPENDIX

  • 11.1 RELATED RESEARCH
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제